Oral dabigatran as effective as enoxaparin in preventing thromboprophylaxis after THA
Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II*). A randomised, double-blind, non-inferiority trialThromb Haemost. 2011 Apr;105(4):721-9. doi: 10.1160/TH10-10-0679. Epub 2011 Jan 12
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
2055 patients undergoing total hip arthroplasty (THA) were randomized to receive oral dabigatran or subcutaneous enoxaparin to compare the impact each pharmaceutical had on the incidence of venous thromboembolism (VTE) and all-cause mortality. Following assessments over a 3 month period, the results displayed that both dabigatran and enoxaparin were equally effective in preventing VTE following TH...
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.Continue